2X Oncology - OV’s spinout - to Participate in Two Upcoming Investor Conferences
Hoersholm, Denmark October 31th 2017 – Oncology Venture Sweden AB (OV:ST) announces that its US spinout 2X Oncology, Inc. ("2X Oncology " or the "Company"), a precision medicine company developing targeted therapeutics to address significant unmet needs in hard-to-treat cancers, will participate in the Life Sciences Summit 2017 on November 1-2 in New York City and the Jefferies 2017 London Healthcare Conference on November 15-16.Chief Executive Officer George O. Elston will participate in and hold 1x1s with investors at both conferences, joined by Chief Financial Officer Jarne Elleholm.